Chronic renal disease

British Medical Journal

Volumn 325, Issue 7355, 2002, Pages 85-90

  Parmar, Malvinder S ^a  

^a Timmins and District Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE; PHOSPHATE; PROTEIN;

ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DYSLIPIDEMIA; EARLY DIAGNOSIS; GLOMERULUS FILTRATION; HYPERTENSION; KIDNEY INJURY; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALNUTRITION; MEDICAL PRACTICE; MEDLINE; ORGANIZATION; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEINURIA; REVIEW; SMOKING;

EID: 0037072116     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.325.7355.85     Document Type: Review

References (29)

1. Serum creatinine levels in the US population: Third national health and nutrition examination survey
2. Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification
3. Assessing renal function from creatinine measurements in adults with chronic renal failure
4. Pathophysiology of progressive nephropathies
5. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
6. Effect of intensive therapy on the development and progression of nephropathy in the DCCT
7. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
8. Meta-analysis of the effects of intensive blood-glucose control on late complications of type I diabetes
9. The effect of angiotensin converting enzyme inhibition on diabetic nephropathy
10. Diabetic nephropathy
11. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 Diabetes
12. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
13. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
14. Randomised controlled trial of dual blockade renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: The candesartan and lisinopril microalbuminuria (CALM) study
15. Is there still a role for a diet very low in protein, with or without supplements, in the management of patients with end-stage renal disease?
16. Effects of dietary protein restriction on the progression of advanced renal disease in the modification of diet in renal disease study
17. Effects of diet and antihypertensive therapy on creatinine clearance and serum creatinine in the modification of diet in renal disease study
18. Effect of lipid reduction on the progression of renal disease: A meta-analysis
19. The importance of dietary calcium and phosphorus in the secondary hyperparathyroidism of patients with early renal failure
20. Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: A cross-sectional study
21. Smoking as a risk factor for end-stage renal failure in men with primary renal disease
22. Smoking a factor promoting onset and progression of diabetic nephropathy
23. The anemia of chronic renal failure
24. The impact of anemia on cardiomyopathy, morbidity and mortality in end-stage renal disease
25. Cardiovascular effects of recombinant human erythropoietin in predialysis patients
26. The long-term effects of recombinant human erythropoietin on the cardiovascular system
27. Guidelines for the treatment of anemia of chronic renal failure
28. European best practice guidelines for the management of anaemia in patients with chronic renal failure
29. Cardiac disease in chronic uremia: Clinical outcomes and risk factors